Literature DB >> 30480717

Trends in First Gabapentin and Pregabalin Prescriptions in Primary Care in the United Kingdom, 1993-2017.

François Montastruc1, Simone Y Loo2, Christel Renoux2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30480717      PMCID： PMC6583557          DOI： 10.1001/jama.2018.12358

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

1.  Error in the Introduction.

Authors: 
Journal:  JAMA       Date:  2019-04-23       Impact factor: 56.272

2.  Gabapentin Use for Hospitalized Neonates.

Authors:  Hibo H Abdi; Nathalie L Maitre; Kristen L Benninger; Mark E Hester; Jonathan L Slaughter
Journal:  Pediatr Neurol       Date:  2019-02-21       Impact factor: 3.372

3.  Patterns of pregabalin initiation and discontinuation after its subsidy in Australia.

Authors:  Tricia Chiu; Jonathan Brett; Sallie-Anne Pearson; Andrea L Schaffer
Journal:  Br J Clin Pharmacol       Date:  2020-03-22       Impact factor: 4.335

4.  Prevalence of Gabapentinoids and Central Nervous System Depressant Drugs, and Their Association with Risk Factors for Respiratory Depression in Primary Care Patients.

Authors:  Eladio Fernández-Liz; Maria Estrella Barceló-Colomer; Laura Gómez-Ganda; Carlota Varon-Galcera; Pilar Lalueza-Broto; Francisco Javier Medel-Rebollo; Maria Angeles Hortelano-García; Elisabeth Martín-Gracia
Journal:  Clin Drug Investig       Date:  2022-04-21       Impact factor: 2.859

5.  Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice.

Authors:  Mahindra Chincholkar
Journal:  Br J Pain       Date:  2020-03-13

6.  Effects of Including Epidemiologic Data in Lumbar Spine Imaging Reports on Prescribing Non-Opioid Medications for Pain.

Authors:  Zachary A Marcum; Laura S Gold; Kathryn T James; Eric N Meier; Judith A Turner; David F Kallmes; Daniel C Cherkin; Richard A Deyo; Karen J Sherman; Patrick H Luetmer; Andrew L Avins; Brent Griffith; Janna L Friedly; Pradeep Suri; Patrick J Heagerty; Jeffrey G Jarvik
Journal:  J Gen Intern Med       Date:  2021-02-08       Impact factor: 6.473

7.  Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records.

Authors:  John Macleod; Colin Steer; Kate Tilling; Rosie Cornish; John Marsden; Tim Millar; John Strang; Matthew Hickman
Journal:  PLoS Med       Date:  2019-11-26       Impact factor: 11.069

8.  Enduring alterations in hippocampal astrocytesynaptic proximity following adolescent alcohol exposure: reversal by gabapentin.

Authors:  Kati L Healey; Sandra Kibble; Sierra Hodges; Kathryn J Reissner; Anze Testen; Tiffany A Wills; Shawn K Acheson; Benjamin M Siemsen; John A McFaddin; Michael D Scofield; H Scott Swartzwelder
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

9.  Spatiotemporal modelling of pregabalin prescribing in England with effect of deprivation.

Authors:  Ziyu Zheng; Benjamin Taylor; Barry Rowlingson; Euan Lawson
Journal:  BMJ Open       Date:  2020-03-23       Impact factor: 2.692

10.  Trends, Patient and Prescriber Characteristics in Gabapentinoid Use in a Sample of United States Ambulatory Care Visits from 2003 to 2016.

Authors:  Lili Zhou; Sandipan Bhattacharjee; C Kent Kwoh; Patrick J Tighe; Daniel C Malone; Marion Slack; Debbie L Wilson; Joshua D Brown; Wei-Hsuan Lo-Ciganic
Journal:  J Clin Med       Date:  2019-12-29       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.